| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 363.7 | 370.4 | 338.7 |
| Other income | 3.9 | 4.0 | 4.0 |
| Total income | 367.6 | 374.4 | 342.8 |
| Profit before exceptional items & tax | 97.3 | 133.2 | 88.8 |
| Exceptional items | 31.8 | 0.0 | 0.0 |
| Profit before tax | 129.1 | 133.2 | 88.8 |
| Net profit | 96.2 | 94.6 | 66.2 |
| Operating margin | 35.1% | 35.6% | 25.9% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +45.30% |
|---|---|
| Net profit, quarter on quarter | +1.70% |
| Revenue, year on year | +7.40% |
| Operating profit, year on year | +10.10% |
| Operating profit, quarter on quarter | -27.70% |
NSE results filing, NSE: PGHL. Figures extracted from the filing.
Procter & Gamble Health Ltd: key numbers
- Share price
- ₹5,234.00
- Market cap
- ₹8,688 Cr
- Revenue (annual)
- ₹1,408 Cr
- Net profit (annual)
- ₹326.9 Cr
- P/E (TTM)
- 24.3×Sector 47.3×
- Promoter holding
- 51.82%+0.00% QoQ
- FII holding
- 6.33%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Health Ltd
All →Procter & Gamble Health Other Announcement
Procter & Gamble Health informed shareholders about an extended SEBI-mandated special window for re-lodging rejected physical share transfer requests until February 4, 2027.
Procter & Gamble Health Management Change
Procter & Gamble Health shareholders approved the re-appointment of Mr. S. Madhavan as an Independent Director for a five-year term starting November 15, 2026.
- Execution
- 5 years
Procter & Gamble Health Annual General Meeting
Procter & Gamble Health held its 59th Annual General Meeting on September 3, 2026, where shareholders discussed financial results and directorial appointments.
Procter & Gamble Health Business Update
Procter & Gamble Health Limited has filed its Business Responsibility & Sustainability Report for the financial year ended March 31, 2026.
Procter & Gamble Health Annual General Meeting
Procter & Gamble Health Ltd has rescheduled its 59th AGM to September 3, 2026. The record date for the final dividend and AGM is August 27, 2026.
Procter & Gamble Health Results Update
Procter & Gamble Health reported a 7% increase in quarterly sales to ₹356 crore. Profit After Tax rose 45% to ₹96 crore, aided by asset sale proceeds.